We are a pharmaceutical company developing affordable novel therapies to serve global patients in high unmet need therapy areas through innovation in small-molecule targeted therapies leveraging AI platforms

Our Focus

High unmet need areas of prevalent diseases within cardio-metabolic therapy area

Diabetes

Disease area with increasing patients globally due to rising risk factors necessitating innovative cost-effective interventions

Read More

Obesity

Condition with increasing attention for innovation across all types of therapies but need options for broader accessibility


Read More

Adjacent Cardio-metabolic

Obesity and Diabetes are major risk factors necessitating interventions to prevent co-existing cardio-metabolic comorbidities


Read More

Our Innovation Approach

Identify small molecule alternatives for proven pathways leveraging AI platform

Small Molecule
Alternatives

Develop small molecule alternatives for validated novel pathways and targets


Read More

AI Platform to De-risk Clinical Success

Identify targets and molecules using Generative AI accelerating drug discovery timelines to develop cost-effective therapies

Read More

Innovate in Emerging Markets

Develop therapies in emerging markets and take these affordable solutions globally


Read More

© 2024 RenaissThera, All Rights Reserved. Designed and Developed by : Right Turn E design